NYSE’s cover photo
NYSE

NYSE

Financial Services

New York, NY 365,867 followers

Connect to a world of opportunity.

About us

The New York Stock Exchange is where icons and disruptors come to build on their success and shape the future. We’ve created the world’s largest and most trusted equities exchange, the leading ETF exchange and the world’s most deterministic trading technology. Our data, technology and expertise help today’s leaders and tomorrow’s visionaries capitalize on opportunity in the public markets.

Industry
Financial Services
Company size
1,001-5,000 employees
Headquarters
New York, NY
Type
Public Company
Founded
1792
Specialties
NYSE, exchange, technology, cash equities, derivatives, listings, futures, options, fixed-income, financial services, NYSE Technologies, connectivity, SFTI, market data, real-time, transactions, and trading solutions

Locations

Employees at NYSE

Updates

  • View organization page for NYSE

    365,867 followers

    "Johanna Grossman, PhD and I, both former bench scientists, get up every day and go to work because we are excited and motivated to help amazing companies raise the capital they need to: further science, improve lives, help providers do their jobs better, and serve patients. Frankly, we're honored to support our corner of the capital markets to make the biotech enterprise possible." -Eric J. Dimise, PhD 🏛️

    View profile for Eric J. Dimise, PhD

    Director, Healthcare & Life Sciences Capital Markets at NYSE, an ICE Company

    𝐈𝐟 𝐲𝐨𝐮'𝐫𝐞 𝐚 𝐩𝐫𝐢𝐯𝐚𝐭𝐞 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐜𝐨𝐦𝐩𝐚𝐧𝐲 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞, 𝐫𝐞𝐚𝐝 𝐨𝐧. My friend and colleague, Johanna Grossman, PhD, NYSE's Head of Healthcare and Life Sciences, Capital Markets, recently spoke with PharmaBoardroom about the efforts we're making at NYSE to support the private #biotech community along the path to the public markets. 𝐈𝐧 𝐭𝐡𝐞 𝐚𝐫𝐭𝐢𝐜𝐥𝐞, 𝐬𝐡𝐞 𝐚𝐝𝐝𝐫𝐞𝐬𝐬𝐞𝐬 𝐭𝐡𝐞𝐬𝐞 𝐯𝐞𝐫𝐲 𝐜𝐨𝐦𝐦𝐨𝐧 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐭𝐡𝐚𝐭 𝐈 𝐡𝐞𝐚𝐫 𝐚𝐛𝐨𝐮𝐭 𝐍𝐘𝐒𝐄 + 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝒂𝒍𝒍 𝒐𝒇 𝒕𝒉𝒆 𝒕𝒊𝒎𝒆: - "𝘐'𝘷𝘦 𝘩𝘦𝘢𝘳𝘥 𝘵𝘩𝘢𝘵 𝘱𝘳𝘦-𝘳𝘦𝘷𝘦𝘯𝘶𝘦 𝘤𝘰𝘮𝘱𝘢𝘯𝘪𝘦𝘴 𝘢𝘳𝘦 𝘯𝘰𝘵 𝘱𝘦𝘳𝘮𝘪𝘵𝘵𝘦𝘥 𝘵𝘰 𝘭𝘪𝘴𝘵 𝘰𝘯 𝘕𝘠𝘚𝘌. 𝘐𝘴 𝘵𝘩𝘢𝘵 𝘵𝘳𝘶𝘦?" [NO, it is NOT true.] - "𝘈𝘴 𝘢 𝘣𝘪𝘰𝘵𝘦𝘤𝘩, 𝘐 𝘯𝘦𝘦𝘥 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘵𝘰𝘱 𝘣𝘪𝘰𝘵𝘦𝘤𝘩 𝘌𝘛𝘍𝘴, 𝘭𝘪𝘬𝘦 𝘵𝘩𝘦 𝘟𝘉𝘐, 𝘐𝘉𝘉, 𝘢𝘯𝘥 𝘍𝘉𝘛. 𝘐 𝘥𝘰𝘯'𝘵 𝘵𝘩𝘪𝘯𝘬 𝘐 𝘤𝘢𝘯 𝘭𝘪𝘴𝘵 𝘸𝘪𝘵𝘩 𝘺𝘰𝘶 𝘢𝘯𝘥 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘩𝘦𝘴𝘦, 𝘴𝘰 𝘸𝘩𝘺 𝘴𝘩𝘰𝘶𝘭𝘥 𝘐 𝘦𝘷𝘦𝘯 𝘤𝘰𝘯𝘴𝘪𝘥𝘦𝘳 𝘕𝘠𝘚𝘌?" [Good news - all of these important biotech ETFs contain NYSE-listed companies. They are exchange agnostic. Read on...] - "𝘞𝘦'𝘳𝘦 𝘢 𝘱𝘳𝘦-𝘳𝘦𝘷𝘦𝘯𝘶𝘦 𝘣𝘪𝘰𝘵𝘦𝘤𝘩 𝘤𝘰𝘮𝘱𝘢𝘯𝘺. 𝘞𝘦 𝘤𝘢𝘯'𝘵 𝘢𝘧𝘧𝘰𝘳𝘥 𝘕𝘠𝘚𝘌." [More good news - read Johanna's commentary to learn about our pre-revenue listing fee relief program.] - "𝘐 𝘴𝘦𝘦 𝘕𝘠𝘚𝘌 𝘰𝘯 𝘛𝘝. 𝘛𝘩𝘦𝘳𝘦 𝘢𝘳𝘦 𝘩𝘢𝘳𝘥𝘭𝘺 𝘢𝘯𝘺 𝘧𝘭𝘰𝘰𝘳 𝘵𝘳𝘢𝘥𝘦𝘳𝘴 𝘢𝘯𝘺𝘮𝘰𝘳𝘦 𝘢𝘯𝘥 𝘐'𝘮 𝘱𝘳𝘦𝘵𝘵𝘺 𝘴𝘶𝘳𝘦 𝘵𝘩𝘦 𝘧𝘰𝘭𝘬𝘴 𝘐 𝘴𝘦𝘦 𝘰𝘯 𝘊𝘕𝘉𝘊 𝘢𝘳𝘦𝘯'𝘵 𝘳𝘦𝘢𝘭𝘭𝘺 𝘥𝘰𝘪𝘯𝘨 𝘢𝘯𝘺𝘵𝘩𝘪𝘯𝘨. 𝘐𝘵'𝘴 2025, 𝘐 𝘤𝘢𝘳𝘦 𝘢𝘣𝘰𝘶𝘵 𝘴𝘱𝘦𝘦𝘥 𝘢𝘯𝘥 𝘦𝘭𝘦𝘤𝘵𝘳𝘰𝘯𝘪𝘤 𝘵𝘳𝘢𝘥𝘪𝘯𝘨." [There's so much wrong here, it's difficult to know where to start! Our Designated Market Makers (DMMs) - those folks in the background on TV - use their own capital to reduce volatility and increase liquidity for NYSE-listed companies. The DMM model is unique to NYSE. They work on behalf of our issuers every day! Read on to learn more...] Johanna and I, both former bench scientists, get up every day and go to work because we are excited and motivated to help amazing companies raise the capital they need to: further science, improve lives, help providers do their jobs better, and serve patients. Frankly, we're honored to support our corner of the capital markets to make the biotech enterprise possible. If you'd like to learn more about all of this, we want to talk to you! Please feel free to DM me or Johanna, but to start - read her interview! 𝐈𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰 𝐋𝐢𝐧𝐤: https://lnkd.in/e4tT6K_U #biotech #healthcare #IPO #innovation #NYSE

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs